Overview

Treatment of Secondary Hyperparathyroidism in the Uremic Patient

Status:
Terminated
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients.
Phase:
N/A
Details
Lead Sponsor:
Zealand University Hospital
Treatments:
Alfacalcidol
Ergocalciferols
Hydroxycholecalciferols